Clinical Trial Operations
临床试验操作
基本信息
- 批准号:9124848
- 负责人:
- 金额:$ 14.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdultAvastinBioinformaticsBiometryBrain NeoplasmsCase Report FormClinicClinicalClinical DataClinical ResearchClinical TrialsCollectionConduct Clinical TrialsConflict of InterestConsentConsent FormsDataData AnalysesData CollectionDatabasesDedicationsDevelopmentDocumentationElectronicsEnrollmentEnsureEpidermal Growth FactorEvaluationFederal GovernmentGliadelGoalsGrantHealth systemHumanHuman ResourcesImmuneImmunologic MonitoringIndividualInformaticsInstitutesInstructionInternationalInvestigationLaboratoriesLaboratory FindingLeadershipMalignant - descriptorMalignant GliomaMalignant NeoplasmsMalignant neoplasm of brainManuscriptsMethodsMonoclonal AntibodiesMutationNurse PractitionersNursing ResearchOncolytic virusesPathologyPatient RecruitmentsPatient-Focused OutcomesPatientsPhasePhase III Clinical TrialsPopulation HeterogeneityPreparationProceduresProcessProtocols documentationPublicationsQualifyingQuality of lifeRadioisotopesRadiopharmaceuticalsRandomizedRecruitment ActivityResearchResearch DesignResearch InfrastructureSafetySample SizeScheduleServicesSideSpecialistStatistical ModelsT-LymphocyteTestingTherapeuticTherapeutic Clinical TrialTissuesTrainingTranslatingTranslational ResearchTranslationsUnited States Food and Drug AdministrationUniversitiesVaccinesWorkbasebiobankchimeric antigen receptorclinical materialcytotoxic radiationdata acquisitiondata managementdesignelectronic dataepidermal growth factor receptor VIIIfollow-upimprovedinnovationmeetingsmembermultidisciplinaryneuro-oncologynovelnovel therapeuticsoperationpeptide vaccinationpre-clinicalprotocol developmentquality assurancereceptorresearch studyscreeningtemozolomidetumor
项目摘要
The Clinical Trial Operations Core will provide the leadership and expertise needed to support the clinical
research of the four Projects of this SPORE grant. The Clinical Trial Operations Core will be Co-Directed by Dr.
Annick Desjardins and Dr. Darell Bigner. Dr. Desjardins will interact with Project leaders to develop clinical
trials based upon the data generated from laboratory investigations. The Clinical Trial Operations Core will
support the actual conduct of SPORE clinical trials, including providing clinicians, research manager, research
nurses, research nurse practitioner, clinical trial coordinators, regulatory personnel and data coordinators. Drs.
Desjardins and Bigner will assure the development, successful conduct, and publication of the clinical trials
coming from the work of the four Projects by assuring the development of all the required documents for the
conduct of the study (e.g., protocols, consent forms, clinical side of IND submission, standard operating
procedures, regulatory management, data collection, and data publication). Core B, biostatistical component,
will provide advice on the design of experimental and clinical studies, including calculating sample sizes and
power; data analysis support (either by performing the analyses within the core or advising qualified personnel
within the projects), including the use of appropriate statistical models and applications of statistical test; and,
when necessary, the development of novel methods to help interpret results from experiments. Additionally, a
member of the biostatistical component will participate in regularly scheduled project meetings to provide
statistical/bioinformatics input and assist in preparing the necessary materials for presentation and publication.
临床试验运营核心将提供支持临床所需的领导和专业知识
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Annick Desjardins其他文献
Annick Desjardins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Annick Desjardins', 18)}}的其他基金
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
项目 1:通过消除调节性 T 细胞来靶向胶质母细胞瘤中的巨细胞病毒抗原
- 批准号:
10477338 - 财政年份:2018
- 资助金额:
$ 14.05万 - 项目类别:
相似海外基金
Cell based miRNA Expression as a Marker of Response to Bevacizumab (Avastin) Therapy of Patients with Colorectal Cancer
基于细胞的 miRNA 表达作为结直肠癌患者对贝伐单抗(阿瓦斯汀)治疗反应的标志
- 批准号:
244723291 - 财政年份:2013
- 资助金额:
$ 14.05万 - 项目类别:
Research Fellowships
MICRO-CT IMAGING OF AVASTIN-TREATED MICE WITH LS174TT TUMORS
阿瓦斯汀治疗的 LS174TT 肿瘤小鼠的显微 CT 成像
- 批准号:
8363176 - 财政年份:2011
- 资助金额:
$ 14.05万 - 项目类别:
MICRO-CT IMAGING OF AVASTIN-TREATED MICE WITH LS174TT TUMORS
阿瓦斯汀治疗的 LS174TT 肿瘤小鼠的显微 CT 成像
- 批准号:
8171601 - 财政年份:2010
- 资助金额:
$ 14.05万 - 项目类别:
Novel Method for the Ocular Iontophoretic Delivery of Avastin and Lucentis
眼部电离子导入阿瓦斯汀和雷珠单抗的新方法
- 批准号:
7927575 - 财政年份:2010
- 资助金额:
$ 14.05万 - 项目类别:
PAZOPANIB COMPARED TO AVASTIN, GLEEVEC, SUTENT FOR TUMOR ANGEIOGENESIS
帕唑帕尼与阿瓦斯汀、格列卫、索坦在肿瘤血管生成方面的比较
- 批准号:
7956899 - 财政年份:2009
- 资助金额:
$ 14.05万 - 项目类别:
PAZOPANIB COMPARED TO AVASTIN, GLEEVEC, SUTENT FOR TUMOR ANGEIOGENESIS
帕唑帕尼与阿瓦斯汀、格列卫、索坦在肿瘤血管生成方面的比较
- 批准号:
7726177 - 财政年份:2008
- 资助金额:
$ 14.05万 - 项目类别:
E2104 TRIAL OF AVASTIN DD ADRIAMYCIN AND CYTOXAN FOLLOWED BY TAXOL IN LYMPH NODE
E2104 阿瓦斯汀 DD 阿霉素和环磷酰胺随后在淋巴结中使用紫杉醇的试验
- 批准号:
7603255 - 财政年份:2007
- 资助金额:
$ 14.05万 - 项目类别:
BIOMARKER AND CLINICAL EVALUATION OF BEVACIZUMAB (AVASTIN) TO DETERMINE THE ROLE
贝伐珠单抗(阿瓦斯汀)的生物标志物和临床评估以确定其作用
- 批准号:
7198483 - 财政年份:2005
- 资助金额:
$ 14.05万 - 项目类别: